Start with Where You Are

• What's your current IPO target window? Options: 6–12 months, 12–18 months, 18–24 months, 24+ months, No set timeline
• How confident are you in that timeline? Options: Very confident, Somewhat confident, Hesitant / depends on milestones, Not confident
• What is your current internal target pre-IPO valuation or valuation range (select closest)? Options: <$1B, $1B–$2B, $2B–$5B, $5B–$10B, >$10B, Undisclosed / custom
• If you can, briefly explain which assumptions drove that valuation (comps, growth, margins, market size, etc.).
• Who on your team is driving the IPO timeline and allocation decisions? Options: CEO, CFO, Board Chair, Lead Bank, Founder(s), Finance Committee / Treasury, Other
• What outcome do you most want a large pre-IPO round to achieve for the company? Options: Strengthen balance sheet, Signal to public investors, Buy time to hit milestones, Fund acquisitions/growth, Other

If We Were Honest About Valuation...

• Are you prepared to accept a pre-IPO valuation materially below public-market expectations to secure a credible crossover anchor? Options: Yes, Maybe, with conditions, No
• What is the minimum pre-IPO valuation (or valuation band) you would reluctantly accept to secure the right anchor investor? Options: >$10B, $5B–$10B, $2B–$5B, $1B–$2B, <$1B, Prefer not to state
• Which factors could justify moving down in valuation (e.g., committed aftermarket support, faster close, strategic partnership)? Options: Aftermarket support, Larger check size, Preferential shareholder composition, Shorter execution timeline, Governance concessions, Other
• How would a lower pre-IPO price affect employee morale, option pools, and your board conversations?
• Would you consider milestone- or tranche-based pricing if it protects valuation while meeting capital needs? Options: Yes, Maybe, No
• If milestone pricing is acceptable, what milestones would feel credible and measurable to you?

Who Actually Holds the Keys?

• What if the person you assume will approve allocation isn't the one with the final say—who could that actually be?
• Please list every decision-maker who must approve a crossover allocation and indicate their likely stance. Options: CFO: Supportive, CFO: Cautious, CFO: Opposed, CEO: Supportive, CEO: Cautious, CEO: Opposed, Board: Supportive, Board: Cautious, Board: Opposed, Lead Bank: Supportive, Lead Bank: Cautious, Lead Bank: Opposed
• Which stakeholder typically runs allocation conversations in practice (who convenes, prepares materials, negotiates)? Options: CFO/Finance, CEO, Lead Bank, Board Chair, General Counsel, Other
• How aligned are your key stakeholders on allocation priorities (signal, cash proceeds, governance, speed)? Options: Fully aligned, Mostly aligned with minor differences, Fragmented / several competing priorities, Unknown
• Who has veto power over material allocation or investor governance terms?
• Describe your internal approval timeline and required board materials for a material pre-IPO investment.

What’s Hidden in the Fine Print?

• Which investor protection would hurt you politically if we asked for it—but might actually be rational from an investor perspective?
• Which of the following protections are deal-breakers for you or require special handling? Options: Full ratchet / price protection, Weighted-average anti-dilution, Board seat or observer, Veto rights on financings or M&A, Exclusive info rights, Lockup carve-outs for founders, None of the above
• What lockup terms do you expect for an anchor compared with founders and employees? Options: Same as founders, Longer than founders, Shorter than founders, Custom per investor
• How sensitive are you to governance requests such as board representation, veto rights, or information covenants? Options: Very sensitive — avoid at all costs, Moderately sensitive — negotiable, Not sensitive — willing to grant if value is clear, Depends on investor
• Do any legacy agreements with existing investors restrict the terms we can offer new crossover investors (e.g., ROFR, anti-dilution clauses)? Options: Yes, No, Not sure
• If yes or unsure, summarize the constraint(s) or where we should look to confirm.

How Much Visibility Do Investors Need to Believe the Story?

• Would your S-1 narrative change materially if a blue-chip crossover investor was not on the cap table? Options: Yes — substantially, Somewhat, No meaningful change
• How would you want us described in your S-1 (anchor long-term holder, strategic partner, passive investor, other)? Options: Anchor long-term holder, Strategic partner offering market credibility, Passive institutional investor, Prefer no specific naming, Other
• Which financial and non-financial metrics must be emphasized in the S-1 to convince public investors? Options: Revenue growth, Gross margin trajectory, Net retention / retention metrics, Path to profitability / Adjusted EBITDA, Customer diversification, Unit economics, Other
• What post-listing behaviors from a crossover investor would most strengthen your IPO signaling (e.g., hold-through lockup, active aftermarket buys, roadshow participation)? Options: Hold-through lockup, Open-market support in first 6 months, Participate in roadshow/investor calls, Introduce institutional investors, None of the above, Other
• Would you consider a side letter documenting aftermarket support commitments, and if so, what level of specificity do you think is reasonable? Options: Yes — specific commitments, Yes — high-level principles, Maybe, No
• How important is the perceived duration (stickiness) of crossover holdings to your target investors? Options: Critical, Important, Nice to have, Not important

Show Me The Diligence Map

• If our public-market analysts reviewed your current diligence materials today, where would they raise the loudest red flags?
• Which of the following diligence items do you have fully prepared and audit-ready? Options: Audited financials (last 3 years), Quarterly management financials, Detailed financial model, Customer contracts and concentration schedule, Cap table and option pool history, Compliance and litigation reports, Other
• Where are the biggest documentation or governance gaps that will require work before we can commit?
• How long would it realistically take your team to assemble a public-market–grade diligence package? Options: <2 weeks, 2–4 weeks, 4–8 weeks, >8 weeks
• Who will coordinate diligence on your side and what are their contact details (name, role, email)?
• Are there sensitive topics (revenue recognition, customer concentration, litigation, related-party transactions) we should pre-brief on before material discussions? Options: Yes — will pre-brief, Yes — but prefer to disclose later, No
• If yes, please describe the area(s) you believe need pre-briefing (briefly).

What Would Make You Sleep Easier After IPO?

• If the first 90 days post-IPO went poorly, who would you expect the market or board to hold accountable—and what would you have wished you'd done differently?
• What are your top three post-IPO risks you want an anchor investor to help mitigate?
• How important is active liquidity management during price discovery to you (rank of urgency)? Options: Top priority — must have support, Important — helpful, Moderate — optional, Low priority — not needed
• Would you accept contractual aftermarket commitments from an anchor (e.g., buy-side support windows, minimum purchase amounts), and to what degree? Options: Yes — specific commitments, Yes — limited/high-level, Maybe, No
• Do you want the anchor to participate in investor calls, roadshows, or introductions after listing? Options: Active participation, Selective participation, Introduce selectively, No participation
• What metrics will you track in the first 6 months post-IPO to judge aftermarket health and anchor effectiveness?

Decide—What Would Make This Deal a No‑Brainer?

• What single change in terms, structure, or timing would convert a 'maybe' into an immediate 'yes' from your board or lead bank?
• Select your top two allocation priorities from the list below. Options: Maximize cash proceeds, Preserve target valuation, Signal high-quality shareholders, Minimize governance concessions, Speed of execution
• What is the minimum anchor check size that would materially influence your bank and board recommendation? Options: <$50M, $50M–$200M, $200M–$500M, $500M–$1B, >$1B
• What deal terms would you consider absolutely non-negotiable (list as bullet points)?
• How quickly could you close a deal with an anchor if terms were agreed—what are the gating legal, board, or regulatory steps and their expected timing?
• Are you open to consortium or co-invest structures to achieve scale; if so, what constraints or preferences do you have? Options: Open to consortium, Prefer single anchor, Open with constraints (governance, exclusivity), Not open

Let's Set Clear Next Steps

• If we were to move forward today, what's the single biggest barrier we'd need to remove to get to a signed term sheet?
• Which documents or approvals must we secure before presenting a term sheet (select all that apply)? Options: Board pre-approval / mandate, Audited financials, Signed NDA, Lead bank support letter, Legal opinion / cap table clean-up, Other
• Who should be our primary point of contact going forward? Please provide name, role, and preferred contact info.
• What meeting cadence would you prefer during diligence and negotiating (weekly, bi-weekly, ad hoc)? Options: Weekly, Bi-weekly, Monthly, Ad hoc / as needed
• Do you have a preferred confidentiality or engagement timeline we should honor (e.g., exclusivity windows, public disclosure timing)? Options: Standard mutual NDA, Mutual NDA + short exclusivity (2–4 weeks), No NDA yet — prefer exploratory, Other
• Anything we haven't asked that would materially affect your willingness to engage with a crossover anchor? Please be candid.

• Data & Current-State Alignment (Prework Sync)
• Valuation & Scenario Modeling Workshop
• S‑1 Narrative & IPO Signaling Workshop
• Aftermarket Support & Market‑Making Plan
• Executive Validation & Board Alignment

• Assign a trading desk lead and create a checklist of settlement and compliance steps.
• Finalize the scenario workbook and create a one‑page executive summary of valuation deltas.
• CFO to update cap table projections reflecting each scenario and circulate.
• Prepare a short memo translating model outputs into negotiation parameters for the lead bank.
• One‑Sentence Recap (State/Consequence/Future)
• Deliver 3 prioritized S‑1 messaging changes that are directly traceable to model outputs.
• Produce draft S‑1 text snippets and investor Q&A language for IR.
• Identify legal disclosure issues and secure commitments to resolve them before filing updates.
• Agree on approval flow and owners for final S‑1 edits.
• Prepare tracked edits of the S‑1 showing proposed anchor disclosures and supporting language.
• Legal counsel to review proposed disclosure language and return redlines.
• IR to draft investor Q&A and a one‑page narrative deck for the roadshow reflecting anchor presence.
• Recap Preferred Scenario & S‑1 Commitments
• Agree on specific, measurable aftermarket support commitments and triggers.
• Document operational steps (side letters, escrow, lockup mechanics) and assign owners.
• Produce a short response playbook for likely stress scenarios.
• Ensure lead bank and trading desk alignment on messaging and execution responsibilities.
• Draft a side‑letter template capturing hold‑through commitments and any trading mechanics for counsel review.
• Introductions & Meeting Objectives
• Prepare investor communication language announcing anchor commitments for use at pricing and in the roadshow.
• One‑Sentence State/Consequence/Future Recap
• Obtain executive and board approval on the target pre‑IPO valuation range and anchor allocation ask.
• Approve the proposed S‑1 disclosure changes and authorize counsel to draft required language.
• Authorize execution of market‑support side letters and operational runbook with named owners.
• Set a clear timeline and owners for presenting to the lead bank and prospective anchor investors.
• Produce a one‑page board memo summarizing decisions and circulating for signature.
• Counsel to draft the definitive side‑letter and disclosure language for board/legal review.
• Schedule a briefing with the lead bank to present the approved valuation ask and signaling plan.
• IR to finalize roadshow messaging and investor Q&A reflecting approved anchor commitments.
• Receive and document a clear one‑sentence current state from the company.
• Agree and quantify the primary consequences that an absent or weak anchor investor would cause.
• Define a one‑sentence future state and 2–3 measurable success metrics for the Solution Experience.
• Confirm all modeling inputs, timelines, and data owners required for valuation scenarios.
• Establish ownership and deadlines for prework deliverables prior to the modeling session.
• CFO to deliver the updated financial model (monthly/quarterly forecast) and headcount/capex plan.
• Provide current cap table with option pools, investor rights, and proposed pre‑IPO round size.
• Share latest S‑1 draft and any external valuation memos or banker indications.
• Schedule the Valuation & Scenario Modeling Workshop and grant model access to the crossover team.
• Recap Preconditions
• Produce 2–3 validated valuation scenarios showing the delta created by a crossover anchor.
• Identify and rank the top 3 financial drivers that change most with an anchor investor.
• Agree on a target pre‑IPO valuation range and allocation ask to present to the lead bank and board.
• Ensure the company and crossover team validate the model outputs as decision‑grade.
• Confirm Modeling Assumptions & Baseline
• Inventory Current S‑1 Narrative Gaps
• One‑Sentence Current State
• Anchors: Hold‑Through vs Flip Scenarios
• Executive Summary: Valuation Impact & Recommended Ask
• Define Market‑Support Tactics
• Consequence Quantification
• Define Core Signaling Themes
• Define Anchor Investor Profile & Parameters
• S‑1 Messaging & Disclosure Summary
• Draft Specific S‑1 Language & Disclosures
• One‑Sentence Future State & Success Metrics
• Aftermarket & Operational Commitments
• Operational & Legal Mechanics
• Run Comparative Valuation Scenarios
• Sensitivity & Stress Tests
• Risk Matrix & Mitigation Plan

• Execute Primary Pre-IPO Equity Investment
• Negotiate Purchase Agreements and Anti-Dilution Terms
• Execute IPO Lockup Commitment
• Draft S-1 Narrative Language
• Deliver Valuation Anchor Pricing Proposal
• Anchor IPO Bookbuilding Allocations
• Introduce Institutional Investors for Roadshow
• Publish Research Initiation Note
• Provide Post-IPO Liquidity Support
• Execute Secondary Share Purchases
• Establish Escrow and Settlement Structures
• Coordinate Pricing with Lead Investment Bank
• Provide Investor Relations Support During Lockup

Execute Primary Pre-IPO Equity Investment

• Are you seeking a primary equity investment in this round? Options: Yes, No, Undecided
• What is the target primary investment size from our firm? Options: $50M-$199M, $200M-$499M, $500M-$999M, $1B+
• What is the expected timing for funding the primary check (months to IPO filing)? Options: 12+ months, 9-12 months, 6-9 months, Less than 6 months
• Which use(s) of proceeds should the primary capital cover? (select all that apply) Options: Balance sheet strengthening, Go-to-market expansion, R&D/capex, M&A/strategic initiatives, Working capital
• Do you require the investment to be structured with preferred terms or straight common? Options: Preferred (liquidation preference/other), Convertible preferred, Common, Flexible/Discuss
• Are there existing investor consents or board approvals required for a primary investment? Options: Yes - investor consent, Yes - board approval, No, Unknown
• Please describe any timeline constraints (regulatory, financial close windows, blackout periods) that would affect executing a primary investment.

Negotiate Purchase Agreements and Anti-Dilution Terms

• Which anti-dilution mechanisms are acceptable or expected (select all that apply)? Options: Full ratchet, Weighted-average, No anti-dilution, Hybrid/negotiable
• Do you have standard purchase agreement templates or clauses we must adhere to? Options: Yes - provide template, No - we use investor template, Open to negotiation
• Are there existing convertible instruments (notes, SAFEs) that require conversion or special treatment in the purchase agreement? Options: Yes - convertible notes, Yes - SAFEs, No, Unknown
• Which investor rights are required or desired (board observer, information rights, pro rata, tag/drag rights)? Options: Board observer, Information rights, Pro rata participation, Tag/drag rights, None/limited
• What protective covenants or closing conditions are non-negotiable for the company or our firm?
• Do you expect side letters or bespoke terms for specific investors (e.g., MFN, preferential allocation)? Options: Yes, No, Possibly - depends on investor
• Describe the desired timeline for completing legal documentation and sign-off. Options: 1-2 weeks, 2-4 weeks, 4-8 weeks, Flexible

Execute IPO Lockup Commitment

• What length of IPO lockup do you expect the investor to commit to (months)? Options: 90 days, 180 days, Custom (specify), No lockup required
• Should the commitment be a full lockup or a hold-through agreement with exceptions for underwriting stabilization? Options: Full lockup, Hold-through with exceptions, Undecided
• Will the lockup need to cover affiliated entities and purchased secondary shares? Options: Yes - affiliates included, No - affiliates excluded, Depends on agreement
• Are there carve-outs expected for certain secondary sales or distributions after IPO? Options: Yes - specified carve-outs, No carve-outs, Undecided
• Who will sign the lockup from the company side (company, selling shareholders, both)? Options: Company, Selling shareholders, Both, TBD
• Do you require escrow or financial guarantees to enforce the lockup commitments? Options: Yes, No, Maybe - discuss structure
• Please specify any regulatory or contractual restrictions that could limit lockup enforcement.

Draft S-1 Narrative Language

• Which narratives should emphasize the anchor investment (select all that apply)? Options: Validation by public investors, Use of proceeds clarity, Governance enhancements, Market positioning/scale
• Do you want explicit disclosure of our firm's ongoing aftermarket support in the S-1? Options: Yes - explicit disclosure, No - keep general, Undecided - legal to advise
• Are there specific financial metrics or scenarios you want highlighted (e.g., ARR run-rate, gross margin targets)?
• Who will own S-1 drafting and coordination with counsel and the lead bank? Options: Company legal counsel, Lead bank/legal, Combined working group
• Do you require pre-approved boilerplate language for investor support, lockup, and allocation commitments? Options: Yes, No, Partial/negotiable
• Please list any disclosure risks or sensitivities the S-1 should avoid or address explicitly.
• What is the target S-1 filing date and desired timeline for finalizing narrative language? Options: >12 weeks, 8-12 weeks, 4-8 weeks, <4 weeks

Deliver Valuation Anchor Pricing Proposal

• What pre-IPO valuation range is management and the board targeting? Options: <$1B, $1B-$3B, $3B-$10B, >$10B
• Should our pricing proposal be presented as a single anchor price, a range, or scenario-based outcomes? Options: Single anchor price, Price range, Scenario-based (3+ cases)
• What valuation methodologies should we prioritize in the proposal (select all that apply)? Options: Comparable public multiples, Discounted cash flow, Precedent private rounds, Revenue run-rate multiples
• Do you require modeling of post-IPO dilution and implied public-market pricing alongside the anchor price? Options: Yes - include dilution modeling, No - anchor price only, Partial - summary
• Are there pricing constraints from other investors or existing financing instruments? Options: Yes - caps or floors, No, Unknown
• What level of confidentiality is required for the pricing proposal distribution? Options: Highly confidential (limited parties), Confidential (board + lead bank), Broadly shared
• Please provide the target timeline for delivering the valuation anchor (days/weeks). Options: <1 week, 1-2 weeks, 2-4 weeks, Flexible

Anchor IPO Bookbuilding Allocations

• What percentage of the IPO book are you expecting our firm to anchor? Options: <5%, 5-15%, 15-30%, >30%
• Should anchor allocations be accompanied by a public commitment to hold-through the IPO? Options: Yes, No, Conditional
• Do you expect priority allocation for roadshow-introduced institutional investors? Options: Yes - priority, No - pro rata, Conditional
• Which investor types should be prioritized in bookbuilding (select all that apply)? Options: Long-only institutions, Public funds/mutuals, Hedge funds/active managers, Pension/sovereign funds, Retail anchors
• Are there pre-defined allocation caps per investor or per investor type? Options: Yes - specify caps, No caps, Undecided
• Who will coordinate allocations between the lead bank and anchor(s)? Options: Lead bank, Company CFO/IR, Anchor lead (us) + lead bank
• Please describe any past allocation preferences or conflicts that should inform the bookbuilding plan.

Introduce Institutional Investors for Roadshow

• Do you want introductions targeted by geography or investor style? Options: Geography, Investor style (value/growth), Both, No preference
• Which geographies should be prioritized for roadshow introductions? Options: North America, Europe, Asia-Pacific, EM markets
• What investor meeting formats are preferred (one-on-one, group, virtual)? Options: One-on-one, Group meetings, Virtual webinars, Hybrid
• Do you require NDA or confidentiality agreements before investor introductions? Options: Yes - NDA required, No - rely on public disclosures, Case-by-case
• Are there investor categories to exclude from introductions (competitors, activists)? Options: Exclude competitors, Exclude activists, No exclusions, Specify in comments
• Please list any high-priority institutional targets or existing relationships we should leverage.
• What is the expected timeline for investor outreach and scheduling? Options: >8 weeks before pricing, 4-8 weeks, 2-4 weeks, <2 weeks

Publish Research Initiation Note

• Do you want a formal initiation research note published prior to IPO or immediately after listing? Options: Pre-IPO, Post-IPO (within 7 days), Both, No note required
• What research tone and focus do you prefer (buy-side long-term, balanced, cautious)? Options: Buy-side long-term, Balanced, Cautious, Custom/strategic messaging
• Which distribution channels should be used for the note (select all that apply)? Options: Sell-side distribution, Proprietary investor network, Public press release, Private investor decks
• Do you require coordination with the company’s communications and legal teams for compliance review? Options: Yes - mandatory coordination, No - independent
• Who will provide company financials and management access for research preparation? Options: Company finance team, Company IR, Lead bank, Combination
• What analyst coverage depth is expected (single initiation, full sector comparables, model build)? Options: Single initiation note, Full model and comps, Top-line thematic note
• Please specify any blackout periods or restrictions that affect publishing timing.

Provide Post-IPO Liquidity Support

• What forms of post-IPO liquidity support are you expecting (select all that apply)? Options: Stabilization buys, VWAP-targeted support, Syndicated follow-on participation, Market making introductions
• For how long after the IPO should liquidity support be provided? Options: 30 days, 90 days, 180 days, Through lockup expiry
• Are there dollar limits or pacing constraints on support transactions? Options: Predefined caps, Flexible subject to market, Undisclosed
• Should liquidity support activities be coordinated with the lead bank's stabilization desk? Options: Yes - coordinate closely, No - independent support, Case-by-case

• Final Binding Term Sheet
• Subscription Agreement
• Side Letter(s)
• Investors' Rights & Governance Agreement
• Lockup & Hold-through Agreement
• Closing Conditions & Deliverables Checklist
• Allocation & Communication Plan (Lead Bank & Board)
• Statement of Work (SOW): S‑1 Narrative & Advisory
• Escrow, Funding & Settlement Instructions
• Regulatory Filings & Legal Opinions
• KYC / AML & Investor Onboarding
• Disclosure Schedules & Escrow Agreements
• Execution & E-Signature Log
• Post-Close Obligations & Escalation Plan

• Post-Close Obligations Confirmation
• Lockup & Aftermarket Monitoring Kickoff
• Investor Onboarding & Allocation Execution Review
• Lessons Learned & Continuous Alignment Workshop
• Monthly Success Metrics & Follow-up Check-in (Recurring)

• Publish the lessons-learned report with prioritized backlog and distribute to stakeholders.
• Provision data feeds and build the lockup/aftermarket dashboard with agreed KPIs.
• Document and circulate the escalation playbook and contact list for rapid response.
• Schedule daily monitoring calls for the first two weeks post-listing and weekly thereafter.
• Run a full simulation of the highest-risk scenario and log lessons for the playbook.
• Opening & Recap of Allocation Principles
• All anchor investors are legally and operationally onboarded or have a clear remediation plan.
• Final allocations and any holdbacks for aftermarket support are documented and agreed with the lead bank.
• Public messaging, S-1 implications, and quiet-period rules are aligned between company, bank, and anchor investors.
• Ownership of ongoing investor relationships and escalation points are assigned.
• Collect outstanding onboarding documents and confirm expected delivery dates for each investor.
• Obtain written confirmation of allocation letters and archive them with the obligations register.
• Submit agreed S-1 amendment language to counsel for incorporation, if required.
• Publish the communications calendar to stakeholders and set notification triggers for quiet-period milestones.
• Objectives, Scope & Ground Rules
• Capture a prioritized list of concrete improvements that address highest-impact post-close issues.
• Assign owners and realistic timelines for each prioritized improvement item.
• Update the playbook and obligations workflows to reflect validated process changes.
• Establish a follow-up cadence to verify implementation and measure impact.
• Welcome & Objectives
• Assign owners and create calendar milestones for each backlog item in the project tracker.
• Update the standard onboarding and monitoring playbooks with agreed changes.
• Schedule a 30/60/90-day implementation review to measure adoption and impact.
• Opening & Agenda Review
• Ensure timely closure or progression of all open action items.
• Maintain visibility into aftermarket health and react to metric deviations rapidly.
• Surface and mitigate near-term risks related to lockup expirations and investor behavior.
• Make timely decisions where cross-functional alignment is required.
• Update the metrics dashboard and circulate before the next meeting.
• Owners to provide written status updates on any blocked actions 48 hours before the next cadence call.
• Prepare decision brief(s) for any items flagged as requiring approval during the meeting.
• Adjust monitoring thresholds or cadence if recurring issues are identified.
• All post-close obligations are explicitly listed and understood by all parties.
• Every obligation has a named owner, deputy, and an agreed delivery date.
• Escalation and compliance controls are defined for breaches or missed milestones.
• A short-term action plan and follow-up cadence are agreed and scheduled.
• Finalize and circulate the obligations register (master spreadsheet) with owners and due dates.
• Upload signed documents and side letters to the secure deal folder and link to the obligations register.
• Set up calendar reminders and dashboard entries for each milestone and reporting date.
• Confirm compliance owner will run weekly checks and alert escalation contacts if thresholds move.
• Purpose & Success Criteria
• Agree on a measurable monitoring framework and the KPIs that will indicate healthy aftermarket trading.
• Confirm data sources, dashboard owners, and reporting cadence for the lockup period.
• Establish clear escalation triggers and a concrete playbook for aftermarket interventions.
• Validate contingency responses through quick scenario runs.
• Close Recap
• Onboarding Status for Anchor Investors
• Lockup Schedule & Exceptions Review
• Status of Open Action Items
• Data Review: Outcomes vs Expectations
• Lockup & Aftermarket Metrics Review
• Allocation Confirmations with Lead Bank
• Obligations Register Review
• Aftermarket Support Commitments
• What Worked / What Didn’t – Structured Feedback
• S-1/Regulatory Disclosure & Messaging
• Investor Feedback & Market Sentiment
• Owner & RACI Assignment
• Root-Cause Analysis on Top Issues
• Monitoring Framework & KPIs